Review: accelerated biological aging in systemic sclerosis and its links to fibrosis
This review argues that systemic sclerosis shows hallmarks of accelerated biological aging, including epigenetic-clock findings, and links genome instability, mitochondrial stress and innate immune activation to fibrosis. It is an abstract of a review, not new patient data. [1]
Automatic summary · not editorially reviewed
The key findings
The review states that systemic sclerosis shares hallmarks of accelerated biological aging, including genomic instability, telomere attrition, mitochondrial dysfunction, cellular senescence and chronic innate immune activation. [1]
Epigenetic clock studies, including DunedinPACE, reportedly show accelerated biological aging in systemic sclerosis, particularly with interstitial lung disease and severe organ involvement. [1]
The review proposes that therapies targeting mitochondrial dysfunction, cGAS-STING signaling and cellular senescence may offer new opportunities to modulate fibrosis, inflammation and immune imbalance. [1]
The source at a glance
- Study type / format
- Narrative review (abstract only)
- Population / context
- People with systemic sclerosis, as discussed in the reviewed literature, including patients with interstitial lung disease and severe organ involvement.
- Summary based on
- Study abstract
- Original publication
- August 5, 2026
Review frames systemic sclerosis as hyper-aging
The review describes systemic sclerosis as a progressive autoimmune disease with fibrosis, vasculopathy and immune dysregulation. It states that emerging evidence shows shared hallmarks of accelerated biological aging: genomic instability, telomere attrition, mitochondrial dysfunction, cellular senescence and chronic innate immune activation. The authors summarize advances from the last 18 months to support the concept of a maladaptive or 'hyper-aging' disorder. This is a framing of the literature, not a demonstrated causal mechanism.
Supporting source [1]
Epigenetic clocks and lung-tissue aging signatures
Recent epigenetic clock studies, including DunedinPACE and other DNA methylation-based aging models, are said to show accelerated biological aging in systemic sclerosis, particularly in patients with interstitial lung disease and severe organ involvement. A gene expression meta-analysis reportedly confirmed that aging and senescence signatures are markedly enriched in lung tissue from systemic sclerosis with interstitial lung disease. These are associations between measured biological age markers and disease features; they do not show that aging causes the disease.
Supporting source [1]
Proposed mechanisms and therapeutic ideas in the review
The review lists aging-associated mechanisms proposed to contribute to disease progression: telomere shortening, mitochondrial dysfunction, micronuclei formation and chromosomal instability. DNA from damaged nuclei or mitochondria is said to activate the cGAS-STING pathway, sustaining type I interferon signaling, inflammaging and fibrotic remodeling. Transcriptomic and spatial studies are cited as supporting a close relationship between metabolic collapse, mitochondrial stress, immune dysregulation and tissue fibrosis. The authors suggest that therapies targeting mitochondrial dysfunction, cGAS-STING signaling and cellular senescence may offer new opportunities; these are proposals, not tested treatments.
Supporting source [1]
How to interpret this
This is an abstract of a review; the full text was not reviewed. It summarizes other studies rather than presenting new patient data, and the abstract reports no sample sizes, follow-up periods or effect estimates. The epigenetic-clock and tissue findings are associations, and the proposed therapeutic targets are ideas, not tested treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Waseem M, Imtiaz A, Datta A, Contreras-Galindo R. · europepmc.org · August 5, 2026